U.S. Markets closed

Amgen Inc. (AMGN)


NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
173.67+1.17 (+0.68%)
At close: 4:00PM EDT

173.67 0.00 (0.00%)
After hours: 5:40PM EDT

People also watch
BIIBGILDCELGMRKBMY
Full screen
Previous Close172.50
Open173.39
Bid173.01 x 100
Ask173.60 x 200
Day's Range172.41 - 174.72
52 Week Range133.64 - 184.21
Volume3,031,821
Avg. Volume3,486,441
Market Cap127.72B
Beta1.76
PE Ratio (TTM)16.50
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield4.60 (2.67%)
Ex-Dividend Date2017-05-15
1y Target EstN/A
Trade prices are not sourced from all markets
  • Barrons.com6 hours ago

    Regeneron: The End of the Outperformance?

    Regeneron Pharmaceuticals (REGN) has been hot this year, so hot in fact that I recommended buying its shares in May, while Jack Hough this month reiterated his bullish call from more than a year ago. Regeneron has benefited from a positive ruling in its patent battle against Amgen (AMGN), and the launch of Dupixent.

  • Benzinga3 days ago

    Deutsche Bank's Take On Big Pharma: 3 Buys And A Hold

    Biotech stocks have been on a tear in the past week, with the iShares NASDAQ Biotechnology Index (ETF) (NASDAQ: IBB ) up 8.8 percent. However, despite the run-up, Deutsche Bank sees more upside ahead for ...

  • If Esperion Wants to Market the Next Big Cholesterol Drug, It Will Take Strategy
    Motley Fool4 days ago

    If Esperion Wants to Market the Next Big Cholesterol Drug, It Will Take Strategy

    Esperion Therapeutics bempedoic acid may help lower bad cholesterol levels, but that doesn't guarantee it will be a blockbuster. For that to happen, it's going to require a plan.